Medizinische Klinik III, Kardiologie und Kreislauferkrankungen.
Institute of Anatomy, Universität Tübingen, Tübingen, Germany.
FASEB J. 2014 Jul;28(7):2864-78. doi: 10.1096/fj.14-249730. Epub 2014 Mar 25.
Platelet-derived SDF-1α (CXCL12) mediates inflammatory and regenerative mechanisms. The present study characterizes the effect of SDF-1α ligation in platelets. SDF-1α (0-100 μM) dose and time dependently caused internalization of its receptor CXCR4 (28.9 ± 1.6 vs. 16.1 ± 1.9 in SDF-1α-treated platelets), coupled to the surface externalization of CXCR7 (65.5 ± 8 vs. 162.8 ± 27.6 following SDF-1α treatment), both in vitro and in vivo. This was inhibited in the presence of AMD3100 (100 μM), CXCR4 blocking and vesicular transport inhibitors (brefeldin A, 10 μM; rapamycin, 100 nM). SDF-1α/CXCR-4-mediated CXCR7 translocation was significantly reduced by inhibitors of ERK1/2-(U0126-10 μM) and cyclophilinA (CyPA)-(NIM811-10 μM) by 28 and 46%, respectively. Further, SDF-1α-induced downstream phosphorylation of Erk1/2 led to CyPA-dependent ubiquitination of CXCR7, which is essential for its surface translocation. CyPA-PPIase-activity inhibitor NIM-811, Erk1/2, and E1-ligase inhibitor-(PYR-41-25 μM) significantly abolished SDF-1α-driven CXCR7 ubiquitination and subsequent surface translocation. SDF-1α induced CXCR7 ubiquitination, and its surface exposure was observed in wild-type murine platelets, but not in CyPA-deficient platelets. SDF-1α/CXCR4-CyPA-dependent CXCR7 translocation and its subsequent ligation attenuated activation-induced apoptosis both in vitro and when administered in vivo. This antiapoptotic effect of SDF-1α was abrogated by blocking CXCR7, also significantly affected in Cypa(-/-) platelets. Thus, we decipher a novel mechanism, whereby SDF-1α regulates relative receptor availability in circulating platelets and exerts its prosurvival benefits.-Chatterjee, M., Seizer, P., Borst, O., Schönberger, T., Mack, A., Geisler, T., Langer, H. F., May, A. E., Vogel, S., Lang, F., Gawaz, M. SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival.
血小板衍生的 SDF-1α(CXCL12)介导炎症和再生机制。本研究描述了 SDF-1α 配体在血小板中的作用。SDF-1α(0-100μM)剂量和时间依赖性地导致其受体 CXCR4 的内化(SDF-1α 处理的血小板中为 28.9±1.6,而 16.1±1.9),同时伴有 CXCR7 的表面外排(体外和体内处理后分别为 65.5±8 和 162.8±27.6)。在存在 AMD3100(100μM)、CXCR4 阻断和囊泡转运抑制剂(布雷菲德菌素 A,10μM;雷帕霉素,100nM)的情况下,这种情况受到抑制。SDF-1α/CXCR-4 介导的 CXCR7 易位分别被 ERK1/2 抑制剂(U0126-10μM)和环孢菌素 A(CyPA)抑制剂(NIM811-10μM)抑制 28%和 46%。此外,SDF-1α 诱导的 Erk1/2 下游磷酸化导致 CyPA 依赖性 CXCR7 泛素化,这对于其表面易位至关重要。CyPA-PPIase 活性抑制剂 NIM-811、Erk1/2 和 E1 连接酶抑制剂(PYR-41-25μM)显著消除了 SDF-1α 驱动的 CXCR7 泛素化及其随后的表面易位。SDF-1α 诱导 CXCR7 泛素化,并在野生型小鼠血小板中观察到其表面暴露,但在 CyPA 缺陷型血小板中则不然。SDF-1α/CXCR4-CyPA 依赖性 CXCR7 易位及其随后的配体在体外和体内给药时均减弱了激活诱导的细胞凋亡。SDF-1α 的这种抗凋亡作用被阻断 CXCR7 所阻断,这在 Cypa(-/-)血小板中也受到显著影响。因此,我们揭示了一种新的机制,即 SDF-1α 调节循环血小板中相对受体的可用性,并发挥其促生存益处。